114 related articles for article (PubMed ID: 8227445)
1. Effect of embolisation of meningioma on Ki-67 proliferation index.
Paulus W; Meixensberger J; Hofmann E; Roggendorf W
J Clin Pathol; 1993 Sep; 46(9):876-7. PubMed ID: 8227445
[TBL] [Abstract][Full Text] [Related]
2. Triple approach for diagnosis and grading of meningiomas: histology, morphometry of Ki-67/Feulgen stainings, and cytogenetics.
Kolles H; Niedermayer I; Schmitt C; Henn W; Feld R; Steudel WI; Zang KD; Feiden W
Acta Neurochir (Wien); 1995; 137(3-4):174-81. PubMed ID: 8789658
[TBL] [Abstract][Full Text] [Related]
3. The relationship between Ki-67 labeling and mitotic index in gliomas and meningiomas: demonstration of the variability of the intermitotic cycle time.
Schröder R; Bien K; Kott R; Meyers I; Vössing R
Acta Neuropathol; 1991; 82(5):389-94. PubMed ID: 1767633
[TBL] [Abstract][Full Text] [Related]
4. The Ki-67 proliferation antigen in meningiomas. Experience in 600 cases.
Roser F; Samii M; Ostertag H; Bellinzona M
Acta Neurochir (Wien); 2004 Jan; 146(1):37-44; discussion 44. PubMed ID: 14740263
[TBL] [Abstract][Full Text] [Related]
5. Proliferation and DNA fragmentation in meningioma subtypes.
Maier H; Wanschitz J; Sedivy R; Rössler K; Ofner D; Budka H
Neuropathol Appl Neurobiol; 1997 Dec; 23(6):496-506. PubMed ID: 9460716
[TBL] [Abstract][Full Text] [Related]
6. Intracranial meningeal tumours in childhood: a clinicopathologic study including MIB-1 immunohistochemistry.
Demirtaş E; Erşahin Y; Yilmaz F; Mutluer S; Veral A
Pathol Res Pract; 2000; 196(3):151-8. PubMed ID: 10729919
[TBL] [Abstract][Full Text] [Related]
7. MIB1 staining index and scoring of histologic features in meningioma. Indicators for the prediction of biologic potential and postoperative management.
Ohta M; Iwaki T; Kitamoto T; Takeshita I; Tateishi J; Fukui M
Cancer; 1994 Dec; 74(12):3176-89. PubMed ID: 7982181
[TBL] [Abstract][Full Text] [Related]
8. Immunohistochemical detection of progesterone receptors and the correlation with Ki-67 labeling indices in paraffin-embedded sections of meningiomas.
Nagashima G; Aoyagi M; Wakimoto H; Tamaki M; Ohno K; Hirakawa K
Neurosurgery; 1995 Sep; 37(3):478-82; discussion 483. PubMed ID: 7501113
[TBL] [Abstract][Full Text] [Related]
9. Meningioangiomatosis. A clinicopathologic study including MIB1 immunoreactivity.
Prayson RA
Arch Pathol Lab Med; 1995 Nov; 119(11):1061-4. PubMed ID: 7487408
[TBL] [Abstract][Full Text] [Related]
10. The significance of Ki-67/MIB-1 labeling index in human meningiomas: a literature study.
Abry E; Thomassen IØ; Salvesen ØO; Torp SH
Pathol Res Pract; 2010 Dec; 206(12):810-5. PubMed ID: 20951502
[TBL] [Abstract][Full Text] [Related]
11. Increased proliferative activity due to necroses induced by pre-operative embolization in benign meningiomas.
Patsouris E; Laas R; Hagel C; Stavrou D
J Neurooncol; 1998 Dec; 40(3):257-64. PubMed ID: 10066099
[TBL] [Abstract][Full Text] [Related]
12. Quantitative growth fraction evaluation with MIB1 and Ki67 antibodies in breast carcinomas.
Barbareschi M; Girlando S; Mauri FM; Forti S; Eccher C; Mauri FA; Togni R; Dalla Palma P; Doglioni C
Am J Clin Pathol; 1994 Aug; 102(2):171-5. PubMed ID: 8042584
[TBL] [Abstract][Full Text] [Related]
13. Comparative investigation of proliferation markers and their prognostic relevance in human meningiomas.
Torp SH; Lindboe CF; Granli US; Moen TM; Nordtømme T
Clin Neuropathol; 2001; 20(5):190-5. PubMed ID: 11594503
[TBL] [Abstract][Full Text] [Related]
14. Which proliferation markers for routine immunohistology? A comparison of five antibodies.
Rose DS; Maddox PH; Brown DC
J Clin Pathol; 1994 Nov; 47(11):1010-4. PubMed ID: 7829674
[TBL] [Abstract][Full Text] [Related]
15. Comparison of MIB-1 (Ki-67) antigen and bromodeoxyuridine proliferation indices in meningiomas.
Langford LA; Cooksley CS; DeMonte F
Hum Pathol; 1996 Apr; 27(4):350-4. PubMed ID: 8617477
[TBL] [Abstract][Full Text] [Related]
16. MIB1 proliferation index in meningiomas: does it predict recurrence? A clinicopathological study.
Tyagi A; Chakrabarty A; Franks A
Br J Neurosurg; 2004 Aug; 18(4):357-61. PubMed ID: 15702834
[TBL] [Abstract][Full Text] [Related]
17. Correlation Between Digital and Manual Determinations of Ki-67/MIB-1 Proliferative Indices in Human Meningiomas.
Pham DT; Skaland I; Winther TL; Salvesen Ø; Torp SH
Int J Surg Pathol; 2020 May; 28(3):273-279. PubMed ID: 31771372
[No Abstract] [Full Text] [Related]
18. MIB-1 staining index and peritumoral brain edema of meningiomas.
Ide M; Jimbo M; Yamamoto M; Umebara Y; Hagiwara S; Kubo O
Cancer; 1996 Jul; 78(1):133-43. PubMed ID: 8646709
[TBL] [Abstract][Full Text] [Related]
19. Detection of the Ki-67 antigen in fixed and wax-embedded sections with the monoclonal antibody MIB1.
McCormick D; Chong H; Hobbs C; Datta C; Hall PA
Histopathology; 1993 Apr; 22(4):355-60. PubMed ID: 8514278
[TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of proliferating cell nuclear antigen (PCNA) in intracranial glioma and meningioma.
Shih YH; Kadota Y; Sato K; Sueyoshi N; Shirai T
Zhonghua Yi Xue Za Zhi (Taipei); 1994 Apr; 53(4):193-7. PubMed ID: 7911730
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
